ZNF251
gene geneOn this page
Summary
ZNF251 (zinc finger protein 251, HGNC:13045) is a protein-coding gene on chromosome 8q24.3, encoding Zinc finger protein 251 (Q9BRH9). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within hematopoietic stem cell homeostasis. Predicted to be active in nucleus.
Source: NCBI Gene 90987 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 106 total
- MANE Select transcript:
NM_138367
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13045 |
| Approved symbol | ZNF251 |
| Name | zinc finger protein 251 |
| Location | 8q24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000198169 |
| Ensembl biotype | protein_coding |
| Entrez | 90987 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 12 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000292562, ENST00000524394, ENST00000525191, ENST00000530353, ENST00000861866, ENST00000861867, ENST00000861868, ENST00000861869, ENST00000861870, ENST00000861871, ENST00000861872, ENST00000917067, ENST00000965159, ENST00000965160
RefSeq mRNA: 1 — MANE Select: NM_138367
NM_138367
CCDS: CCDS47944
Canonical transcript exons
ENST00000292562 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001209809 | 144753683 | 144753796 |
| ENSE00001209827 | 144755405 | 144755531 |
| ENSE00001428382 | 144720909 | 144723382 |
| ENSE00003367540 | 144754192 | 144754321 |
| ENSE00003542789 | 144754696 | 144754803 |
Expression profiles
Bgee: expression breadth ubiquitous, 140 present calls, max score 92.77.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.0646 / max 46.0107, expressed in 1733 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 95706 | 6.0494 | 1714 |
| 95707 | 0.7875 | 412 |
| 95705 | 0.2277 | 90 |
Top tissues by expression
140 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cerebellar hemisphere | UBERON:0002245 | 92.77 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 92.73 | gold quality |
| cerebellar cortex | UBERON:0002129 | 92.70 | gold quality |
| cerebellum | UBERON:0002037 | 92.54 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 91.38 | gold quality |
| apex of heart | UBERON:0002098 | 90.91 | gold quality |
| thyroid gland | UBERON:0002046 | 90.87 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 90.81 | gold quality |
| pituitary gland | UBERON:0000007 | 89.71 | gold quality |
| adenohypophysis | UBERON:0002196 | 89.34 | gold quality |
| metanephros cortex | UBERON:0010533 | 89.23 | gold quality |
| right uterine tube | UBERON:0001302 | 89.12 | gold quality |
| body of uterus | UBERON:0009853 | 88.59 | gold quality |
| endocervix | UBERON:0000458 | 88.44 | gold quality |
| right ovary | UBERON:0002118 | 88.22 | gold quality |
| right coronary artery | UBERON:0001625 | 87.83 | gold quality |
| tibial nerve | UBERON:0001323 | 87.78 | gold quality |
| left uterine tube | UBERON:0001303 | 87.41 | gold quality |
| left ovary | UBERON:0002119 | 87.39 | gold quality |
| ovary | UBERON:0000992 | 87.36 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 87.24 | gold quality |
| mucosa of stomach | UBERON:0001199 | 87.17 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 87.00 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 86.87 | gold quality |
| myometrium | UBERON:0001296 | 86.84 | gold quality |
| popliteal artery | UBERON:0002250 | 86.82 | gold quality |
| tibial artery | UBERON:0007610 | 86.82 | gold quality |
| fallopian tube | UBERON:0003889 | 86.73 | gold quality |
| lower esophagus | UBERON:0013473 | 86.69 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 86.68 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.02 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2687.1 | ZNF251 | Factors with multiple dispersed zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605368
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
34 targeting ZNF251, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-4496 | 99.88 | 68.89 | 2236 |
| HSA-MIR-6817-3P | 99.79 | 68.35 | 2126 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-6892-3P | 99.68 | 66.40 | 1178 |
| HSA-MIR-10393-5P | 99.65 | 68.01 | 1368 |
| HSA-MIR-4261 | 99.59 | 70.30 | 3415 |
| HSA-MIR-4672 | 99.50 | 71.58 | 2893 |
| HSA-MIR-548G-3P | 99.48 | 68.67 | 2159 |
| HSA-MIR-147B-5P | 99.45 | 70.62 | 2432 |
| HSA-MIR-12113 | 99.32 | 67.54 | 1072 |
| HSA-MIR-6731-5P | 99.28 | 67.42 | 2375 |
| HSA-MIR-8085 | 99.28 | 67.56 | 2362 |
| HSA-MIR-3199 | 99.17 | 65.19 | 696 |
| HSA-MIR-8052 | 99.17 | 65.01 | 719 |
| HSA-MIR-4796-3P | 99.08 | 68.38 | 1681 |
| HSA-MIR-452-3P | 99.01 | 66.25 | 1241 |
| HSA-MIR-374A-3P | 98.87 | 67.82 | 1531 |
| HSA-MIR-4539 | 98.78 | 67.18 | 888 |
| HSA-MIR-513B-3P | 98.76 | 68.12 | 1577 |
| HSA-MIR-7977 | 98.65 | 66.18 | 2590 |
| HSA-MIR-4463 | 98.56 | 66.05 | 1071 |
| HSA-MIR-6880-5P | 98.08 | 65.59 | 1282 |
| HSA-MIR-4443 | 98.02 | 66.25 | 1928 |
| HSA-MIR-3977 | 98.00 | 68.17 | 1500 |
| HSA-MIR-4736 | 97.96 | 65.89 | 1287 |
| HSA-MIR-637 | 97.91 | 64.05 | 1517 |
| HSA-MIR-6747-3P | 97.73 | 64.84 | 1596 |
| HSA-MIR-1270 | 96.94 | 66.65 | 931 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp251 | ENSMUSG00000022526 |
| rattus_norvegicus | Zfp251 | ENSRNOG00000030308 |
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 251 — Q9BRH9 (reviewed: Q9BRH9)
All UniProt accessions (2): Q9BRH9, H0YCK5
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_612376* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (21 total): zinc finger region 14, cross-link 4, chain 1, domain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BRH9-F1 | 63.57 | 0.08 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (4): 114, 157, 162, 403
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 0 (showing top):
GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), hematopoietic stem cell homeostasis (GO:0061484), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872), sequence-specific double-stranded DNA binding (GO:1990837)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| homeostasis of number of cells | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
276 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF251 | WFDC12 | Q8WWY7 | 564 |
| ZNF251 | PNMA5 | Q96PV4 | 559 |
| ZNF251 | CCDC57 | Q2TAC2 | 499 |
| ZNF251 | MORN1 | Q5T089 | 475 |
| ZNF251 | RNF113A | O15541 | 427 |
| ZNF251 | ZDBF2 | Q9HCK1 | 411 |
| ZNF251 | MEGF6 | O75095 | 404 |
| ZNF251 | PNMA3 | Q9UL41 | 403 |
| ZNF251 | CCDC51 | Q96ER9 | 395 |
| ZNF251 | ZDHHC9 | Q9Y397 | 393 |
| ZNF251 | GPRIN2 | O60269 | 380 |
| ZNF251 | FBXO40 | Q9UH90 | 375 |
| ZNF251 | THAP3 | Q8WTV1 | 373 |
| ZNF251 | EVA1B | Q9NVM1 | 371 |
| ZNF251 | PCDHGA4 | Q9Y5G9 | 349 |
IntAct
27 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRTAP10-9 | ZNF251 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM41 | ZNF251 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FHL5 | ZNF251 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF251 | E2 | psi-mi:“MI:0915”(physical association) | 0.490 |
| PB2 | ZNF251 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZNF251 | TRIM28 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZNF251 | PB2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SMAD1 | ZNF251 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF460 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| LTBP2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF251 | E2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| BIN1 | ZNF251 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF251 | KRTAP10-9 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF251 | TRIM41 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF251 | FHL5 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RBM11 | ZNF251 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RSPH1 | ZNF251 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (22): ZNF251 (Two-hybrid), ZNF251 (Two-hybrid), ZNF251 (Two-hybrid), ZNF251 (Two-hybrid), ZNF251 (Two-hybrid), KRTAP10-9 (Two-hybrid), ZNF251 (Proximity Label-MS), ZNF251 (Affinity Capture-MS), ZNF251 (Affinity Capture-MS), ZNF251 (Affinity Capture-MS), ZNF251 (Two-hybrid), ZNF251 (Affinity Capture-MS), ZNF251 (Proximity Label-MS), ZNF251 (Two-hybrid), ZNF251 (Two-hybrid)
ESM2 similar proteins: A0JNB1, A1YF12, A1YG88, A2T759, B2RUI1, O43296, O75123, P10072, P17020, P17021, P17097, P51814, P52740, P52741, Q07230, Q08ER8, Q13398, Q14590, Q32KN0, Q3KQV3, Q3MIS6, Q4V8A8, Q5CZA5, Q5RBQ3, Q5RBX0, Q5RCD9, Q5RCX4, Q6GQR8, Q6NX45, Q6P9A3, Q6PK81, Q7TSH9, Q7TSI0, Q7Z7L9, Q86UD4, Q8BFS8, Q8BLB0, Q8IVP9, Q8IZ26, Q8TAU3
Diamond homologs: A0JPL0, A2A761, A3KN32, A3KN36, A6NFI3, A6NM28, A6QLU5, A6QPT6, A7MBI1, A8MTY0, B2RXC5, B4DU55, E9PYI1, O14978, O60765, O75467, O75820, O95780, P0C7X2, P0DKX0, P0DPD5, P10072, P15622, P16374, P17014, P17023, P17032, P17098, P51523, P51786, P52738, P52742, Q02975, Q06732, Q08DG8, Q08ER8, Q0VCB0, Q14590, Q14929, Q29RZ4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
106 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 95 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1207 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:144753677:TCTCA:T | donor_loss | 1.0000 |
| 8:144753678:CTCA:C | donor_loss | 1.0000 |
| 8:144753679:TCAC:T | donor_loss | 1.0000 |
| 8:144753680:CA:C | donor_loss | 1.0000 |
| 8:144753681:ACCTT:A | donor_loss | 1.0000 |
| 8:144753682:C:G | donor_loss | 1.0000 |
| 8:144753682:CCTTT:C | donor_gain | 1.0000 |
| 8:144754207:T:A | donor_gain | 1.0000 |
| 8:144753792:GAATC:G | acceptor_gain | 0.9900 |
| 8:144753795:TC:T | acceptor_gain | 0.9900 |
| 8:144753795:TCCTG:T | acceptor_loss | 0.9900 |
| 8:144753796:CC:C | acceptor_gain | 0.9900 |
| 8:144753797:C:CC | acceptor_gain | 0.9900 |
| 8:144753798:T:G | acceptor_loss | 0.9900 |
| 8:144754186:CCTCA:C | donor_loss | 0.9900 |
| 8:144754187:CTCAC:C | donor_loss | 0.9900 |
| 8:144754188:TCA:T | donor_loss | 0.9900 |
| 8:144754190:A:AC | donor_gain | 0.9900 |
| 8:144754190:AC:A | donor_gain | 0.9900 |
| 8:144754190:ACCC:A | donor_loss | 0.9900 |
| 8:144754191:C:CC | donor_gain | 0.9900 |
| 8:144754191:C:CG | donor_loss | 0.9900 |
| 8:144754191:CC:C | donor_gain | 0.9900 |
| 8:144754208:C:A | donor_gain | 0.9900 |
| 8:144754230:T:TA | donor_gain | 0.9900 |
| 8:144754231:C:A | donor_gain | 0.9900 |
| 8:144754320:TC:T | acceptor_gain | 0.9900 |
| 8:144754320:TCC:T | acceptor_loss | 0.9900 |
| 8:144754321:CC:C | acceptor_gain | 0.9900 |
| 8:144754322:CTGCA:C | acceptor_loss | 0.9900 |
AlphaMissense
4446 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 8:144722250:G:C | F470L | 0.999 |
| 8:144722250:G:T | F470L | 0.999 |
| 8:144722252:A:G | F470L | 0.999 |
| 8:144722166:G:C | F498L | 0.998 |
| 8:144722166:G:T | F498L | 0.998 |
| 8:144722168:A:G | F498L | 0.998 |
| 8:144722334:A:C | F442L | 0.998 |
| 8:144722334:A:T | F442L | 0.998 |
| 8:144722336:A:G | F442L | 0.998 |
| 8:144722418:A:C | F414L | 0.998 |
| 8:144722418:A:T | F414L | 0.998 |
| 8:144722420:A:G | F414L | 0.998 |
| 8:144722502:G:C | F386L | 0.998 |
| 8:144722502:G:T | F386L | 0.998 |
| 8:144722504:A:G | F386L | 0.998 |
| 8:144722670:A:C | F330L | 0.998 |
| 8:144722670:A:T | F330L | 0.998 |
| 8:144722672:A:G | F330L | 0.998 |
| 8:144722754:G:C | F302L | 0.998 |
| 8:144722754:G:T | F302L | 0.998 |
| 8:144722756:A:G | F302L | 0.998 |
| 8:144722233:A:G | L476P | 0.997 |
| 8:144722586:G:C | F358L | 0.997 |
| 8:144722586:G:T | F358L | 0.997 |
| 8:144722588:A:G | F358L | 0.997 |
| 8:144722218:C:G | R481P | 0.996 |
| 8:144722470:C:G | R397P | 0.996 |
| 8:144722838:A:C | F274L | 0.996 |
| 8:144722838:A:T | F274L | 0.996 |
| 8:144722840:A:G | F274L | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000093074 (8:144744017 T>A,G), RS1000254132 (8:144755702 A>C,G,T), RS1000431339 (8:144750185 C>T), RS1000488759 (8:144752428 T>C), RS1000520994 (8:144744513 G>C), RS1000612168 (8:144746782 C>G,T), RS1000624806 (8:144726911 G>A), RS1000658141 (8:144744742 G>A,C), RS1000798665 (8:144740730 T>TC), RS1000824292 (8:144739481 C>T), RS1000865575 (8:144749935 C>T), RS1000985602 (8:144731815 T>G), RS1001046253 (8:144746498 A>G), RS1001063168 (8:144731428 G>C), RS1001120272 (8:144726362 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007005_4 | Logical memory (immediate recall) in normal cognition | 2.000000e-07 |
| GCST90011898_110 | Alanine aminotransferase levels | 5.000000e-25 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004874 | memory performance |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Nickel | decreases expression | 2 |
| Cadmium Chloride | decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| beta-lapachone | decreases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| manganese chloride | increases abundance, increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | decreases expression | 1 |
| PCI 5002 | affects cotreatment, increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Folic Acid | decreases expression | 1 |
| Manganese | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Zinc | affects cotreatment, increases expression | 1 |
| Gold Compounds | decreases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.